In APP/PS1 mouse model, TRPML1 has been reported to alleviate cognitive impairment in AD by mediating neuron autophagy and reducing autophagosome accumulation through the PPARγ/AMPK/mTOR signaling pathway [13]. This evidence concerns the gene APP and Alzheimer disease.